Global Dermatological Drugs Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Publisher Name :
Date: 12-Oct-2018
No. of pages: 130

Dermatology is a field of medicine that is engaged in the diagnosis, prevention, and treatment of various skin, nails, hair diseases, pigmentation, acne, wrinkles, psoriasis, and others.

Scope of the Report:

This report focuses on the Dermatological Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Different techniques are used in dermatology such as topical & systemic medications, laser therapy, radio therapy, photodynamic therapy, vitiligo surgery, dermatological surgery, and others.

The worldwide market for Dermatological Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

- Bayer

- Johnson & Johnson

- Pfizer

- Novartis

- GlaxoSmithKline

- AstraZeneca

- Galderma

- Amgen

- AbbVie

- Merck

Market Segment by Regions, regional analysis covers

- North America (United States, Canada and Mexico)

- Europe (Germany, France, UK, Russia and Italy)

- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

- South America (Brazil, Argentina, Colombia etc.)

- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

- Prescription-Based Drugs

- Over-the-Counter Drugs

Market Segment by Applications, can be divided into

- Acne

- Skin Infections

- Psoriasis

- Dermatitis Drugs

- Other

There are 15 Chapters to deeply display the global Dermatological Drugs market.

Chapter 1, to describe Dermatological Drugs Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Dermatological Drugs, with sales, revenue, and price of Dermatological Drugs, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Dermatological Drugs, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Dermatological Drugs market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Dermatological Drugs sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Global Dermatological Drugs Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Table of Contents

1 Market Overview
1.1 Dermatological Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Prescription-Based Drugs
1.2.2 Over-the-Counter Drugs
1.3 Market Analysis by Applications
1.3.1 Acne
1.3.2 Skin Infections
1.3.3 Psoriasis
1.3.4 Dermatitis Drugs
1.3.5 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Bayer
2.1.1 Business Overview
2.1.2 Dermatological Drugs Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Bayer Dermatological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Johnson & Johnson
2.2.1 Business Overview
2.2.2 Dermatological Drugs Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Johnson & Johnson Dermatological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Pfizer
2.3.1 Business Overview
2.3.2 Dermatological Drugs Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Pfizer Dermatological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Novartis
2.4.1 Business Overview
2.4.2 Dermatological Drugs Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Novartis Dermatological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 GlaxoSmithKline
2.5.1 Business Overview
2.5.2 Dermatological Drugs Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 GlaxoSmithKline Dermatological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 AstraZeneca
2.6.1 Business Overview
2.6.2 Dermatological Drugs Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 AstraZeneca Dermatological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Galderma
2.7.1 Business Overview
2.7.2 Dermatological Drugs Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Galderma Dermatological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Amgen
2.8.1 Business Overview
2.8.2 Dermatological Drugs Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Amgen Dermatological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 AbbVie
2.9.1 Business Overview
2.9.2 Dermatological Drugs Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 AbbVie Dermatological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Merck
2.10.1 Business Overview
2.10.2 Dermatological Drugs Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Merck Dermatological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Dermatological Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Dermatological Drugs Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Dermatological Drugs Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Dermatological Drugs Manufacturer Market Share in 2017
3.3.2 Top 6 Dermatological Drugs Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Dermatological Drugs Market Analysis by Regions
4.1 Global Dermatological Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Dermatological Drugs Sales and Market Share by Regions (2013-2018)
4.1.2 Global Dermatological Drugs Revenue and Market Share by Regions (2013-2018)
4.2 North America Dermatological Drugs Sales and Growth Rate (2013-2018)
4.3 Europe Dermatological Drugs Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Dermatological Drugs Sales and Growth Rate (2013-2018)
4.5 South America Dermatological Drugs Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Dermatological Drugs Sales and Growth Rate (2013-2018)
5 North America Dermatological Drugs by Countries
5.1 North America Dermatological Drugs Sales, Revenue and Market Share by Countries
5.1.1 North America Dermatological Drugs Sales and Market Share by Countries (2013-2018)
5.1.2 North America Dermatological Drugs Revenue and Market Share by Countries (2013-2018)
5.2 United States Dermatological Drugs Sales and Growth Rate (2013-2018)
5.3 Canada Dermatological Drugs Sales and Growth Rate (2013-2018)
5.4 Mexico Dermatological Drugs Sales and Growth Rate (2013-2018)
6 Europe Dermatological Drugs by Countries
6.1 Europe Dermatological Drugs Sales, Revenue and Market Share by Countries
6.1.1 Europe Dermatological Drugs Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Dermatological Drugs Revenue and Market Share by Countries (2013-2018)
6.2 Germany Dermatological Drugs Sales and Growth Rate (2013-2018)
6.3 UK Dermatological Drugs Sales and Growth Rate (2013-2018)
6.4 France Dermatological Drugs Sales and Growth Rate (2013-2018)
6.5 Russia Dermatological Drugs Sales and Growth Rate (2013-2018)
6.6 Italy Dermatological Drugs Sales and Growth Rate (2013-2018)
7 Asia-Pacific Dermatological Drugs by Countries
7.1 Asia-Pacific Dermatological Drugs Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Dermatological Drugs Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Dermatological Drugs Revenue and Market Share by Countries (2013-2018)
7.2 China Dermatological Drugs Sales and Growth Rate (2013-2018)
7.3 Japan Dermatological Drugs Sales and Growth Rate (2013-2018)
7.4 Korea Dermatological Drugs Sales and Growth Rate (2013-2018)
7.5 India Dermatological Drugs Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Dermatological Drugs Sales and Growth Rate (2013-2018)
8 South America Dermatological Drugs by Countries
8.1 South America Dermatological Drugs Sales, Revenue and Market Share by Countries
8.1.1 South America Dermatological Drugs Sales and Market Share by Countries (2013-2018)
8.1.2 South America Dermatological Drugs Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Dermatological Drugs Sales and Growth Rate (2013-2018)
8.3 Argentina Dermatological Drugs Sales and Growth Rate (2013-2018)
8.4 Colombia Dermatological Drugs Sales and Growth Rate (2013-2018)
9 Middle East and Africa Dermatological Drugs by Countries
9.1 Middle East and Africa Dermatological Drugs Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Dermatological Drugs Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Dermatological Drugs Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Dermatological Drugs Sales and Growth Rate (2013-2018)
9.3 UAE Dermatological Drugs Sales and Growth Rate (2013-2018)
9.4 Egypt Dermatological Drugs Sales and Growth Rate (2013-2018)
9.5 Nigeria Dermatological Drugs Sales and Growth Rate (2013-2018)
9.6 South Africa Dermatological Drugs Sales and Growth Rate (2013-2018)
10 Global Dermatological Drugs Market Segment by Type
10.1 Global Dermatological Drugs Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Dermatological Drugs Sales and Market Share by Type (2013-2018)
10.1.2 Global Dermatological Drugs Revenue and Market Share by Type (2013-2018)
10.2 Prescription-Based Drugs Sales Growth and Price
10.2.1 Global Prescription-Based Drugs Sales Growth (2013-2018)
10.2.2 Global Prescription-Based Drugs Price (2013-2018)
10.3 Over-the-Counter Drugs Sales Growth and Price
10.3.1 Global Over-the-Counter Drugs Sales Growth (2013-2018)
10.3.2 Global Over-the-Counter Drugs Price (2013-2018)
11 Global Dermatological Drugs Market Segment by Application
11.1 Global Dermatological Drugs Sales Market Share by Application (2013-2018)
11.2 Acne Sales Growth (2013-2018)
11.3 Skin Infections Sales Growth (2013-2018)
11.4 Psoriasis Sales Growth (2013-2018)
11.5 Dermatitis Drugs Sales Growth (2013-2018)
11.6 Other Sales Growth (2013-2018)
12 Dermatological Drugs Market Forecast (2018-2023)
12.1 Global Dermatological Drugs Sales, Revenue and Growth Rate (2018-2023)
12.2 Dermatological Drugs Market Forecast by Regions (2018-2023)
12.2.1 North America Dermatological Drugs Market Forecast (2018-2023)
12.2.2 Europe Dermatological Drugs Market Forecast (2018-2023)
12.2.3 Asia-Pacific Dermatological Drugs Market Forecast (2018-2023)
12.2.4 South America Dermatological Drugs Market Forecast (2018-2023)
12.2.5 Middle East and Africa Dermatological Drugs Market Forecast (2018-2023)
12.3 Dermatological Drugs Market Forecast by Type (2018-2023)
12.3.1 Global Dermatological Drugs Sales Forecast by Type (2018-2023)
12.3.2 Global Dermatological Drugs Market Share Forecast by Type (2018-2023)
12.4 Dermatological Drugs Market Forecast by Application (2018-2023)
12.4.1 Global Dermatological Drugs Sales Forecast by Application (2018-2023)
12.4.2 Global Dermatological Drugs Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Dermatological Drugs Picture
Table Product Specifications of Dermatological Drugs
Figure Global Sales Market Share of Dermatological Drugs by Types in 2017
Table Dermatological Drugs Types for Major Manufacturers
Figure Prescription-Based Drugs Picture
Figure Over-the-Counter Drugs Picture
Figure Dermatological Drugs Sales Market Share by Applications in 2017
Figure Acne Picture
Figure Skin Infections Picture
Figure Psoriasis Picture
Figure Dermatitis Drugs Picture
Figure Other Picture
Figure United States Dermatological Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Dermatological Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Dermatological Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Dermatological Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure France Dermatological Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure UK Dermatological Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Dermatological Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Dermatological Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure China Dermatological Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Dermatological Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Dermatological Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure India Dermatological Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Dermatological Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Dermatological Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Dermatological Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Dermatological Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Dermatological Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Dermatological Drugs Revenue (Value) and Growth Rate (2013-2023)
Table Bayer Basic Information, Manufacturing Base and Competitors
Table Bayer Dermatological Drugs Type and Applications
Table Bayer Dermatological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table Johnson & Johnson Dermatological Drugs Type and Applications
Table Johnson & Johnson Dermatological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Dermatological Drugs Type and Applications
Table Pfizer Dermatological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Dermatological Drugs Type and Applications
Table Novartis Dermatological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table GlaxoSmithKline Dermatological Drugs Type and Applications
Table GlaxoSmithKline Dermatological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table AstraZeneca Basic Information, Manufacturing Base and Competitors
Table AstraZeneca Dermatological Drugs Type and Applications
Table AstraZeneca Dermatological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Galderma Basic Information, Manufacturing Base and Competitors
Table Galderma Dermatological Drugs Type and Applications
Table Galderma Dermatological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Amgen Basic Information, Manufacturing Base and Competitors
Table Amgen Dermatological Drugs Type and Applications
Table Amgen Dermatological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table AbbVie Basic Information, Manufacturing Base and Competitors
Table AbbVie Dermatological Drugs Type and Applications
Table AbbVie Dermatological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Dermatological Drugs Type and Applications
Table Merck Dermatological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Global Dermatological Drugs Sales by Manufacturer (2016-2017)
Figure Global Dermatological Drugs Sales Market Share by Manufacturer in 2016
Figure Global Dermatological Drugs Sales Market Share by Manufacturer in 2017
Table Global Dermatological Drugs Revenue by Manufacturer (2016-2017)
Figure Global Dermatological Drugs Revenue Market Share by Manufacturer in 2016
Figure Global Dermatological Drugs Revenue Market Share by Manufacturer in 2017
Figure Top 3 Dermatological Drugs Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Dermatological Drugs Manufacturer (Revenue) Market Share in 2017
Figure Global Dermatological Drugs Sales and Growth Rate (2013-2018)
Figure Global Dermatological Drugs Revenue and Growth Rate (2013-2018)
Table Global Dermatological Drugs Sales by Regions (2013-2018)
Table Global Dermatological Drugs Sales Market Share by Regions (2013-2018)
Table Global Dermatological Drugs Revenue by Regions (2013-2018)
Figure Global Dermatological Drugs Revenue Market Share by Regions in 2013
Figure Global Dermatological Drugs Revenue Market Share by Regions in 2017
Figure North America Dermatological Drugs Sales and Growth Rate (2013-2018)
Figure Europe Dermatological Drugs Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Dermatological Drugs Sales and Growth Rate (2013-2018)
Figure South America Dermatological Drugs Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Dermatological Drugs Sales and Growth Rate (2013-2018)
Figure North America Dermatological Drugs Revenue and Growth Rate (2013-2018)
Table North America Dermatological Drugs Sales by Countries (2013-2018)
Table North America Dermatological Drugs Sales Market Share by Countries (2013-2018)
Figure North America Dermatological Drugs Sales Market Share by Countries in 2013
Figure North America Dermatological Drugs Sales Market Share by Countries in 2017
Table North America Dermatological Drugs Revenue by Countries (2013-2018)
Table North America Dermatological Drugs Revenue Market Share by Countries (2013-2018)
Figure North America Dermatological Drugs Revenue Market Share by Countries in 2013
Figure North America Dermatological Drugs Revenue Market Share by Countries in 2017
Figure United States Dermatological Drugs Sales and Growth Rate (2013-2018)
Figure Canada Dermatological Drugs Sales and Growth Rate (2013-2018)
Figure Mexico Dermatological Drugs Sales and Growth Rate (2013-2018)
Figure Europe Dermatological Drugs Revenue and Growth Rate (2013-2018)
Table Europe Dermatological Drugs Sales by Countries (2013-2018)
Table Europe Dermatological Drugs Sales Market Share by Countries (2013-2018)
Table Europe Dermatological Drugs Revenue by Countries (2013-2018)
Figure Europe Dermatological Drugs Revenue Market Share by Countries in 2016
Figure Europe Dermatological Drugs Revenue Market Share by Countries in 2017
Figure Germany Dermatological Drugs Sales and Growth Rate (2013-2018)
Figure UK Dermatological Drugs Sales and Growth Rate (2013-2018)
Figure France Dermatological Drugs Sales and Growth Rate (2013-2018)
Figure Russia Dermatological Drugs Sales and Growth Rate (2013-2018)
Figure Italy Dermatological Drugs Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Dermatological Drugs Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Dermatological Drugs Sales by Countries (2013-2018)
Table Asia-Pacific Dermatological Drugs Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Dermatological Drugs Sales Market Share by Countries 2017
Table Asia-Pacific Dermatological Drugs Revenue by Countries (2013-2018)
Figure Asia-Pacific Dermatological Drugs Revenue Market Share by Countries 2017
Figure China Dermatological Drugs Sales and Growth Rate (2013-2018)
Figure Japan Dermatological Drugs Sales and Growth Rate (2013-2018)
Figure Korea Dermatological Drugs Sales and Growth Rate (2013-2018)
Figure India Dermatological Drugs Sales and Growth Rate (2013-2018)
Figure Southeast Asia Dermatological Drugs Sales and Growth Rate (2013-2018)
Figure South America Dermatological Drugs Revenue and Growth Rate (2013-2018)
Table South America Dermatological Drugs Sales by Countries (2013-2018)
Table South America Dermatological Drugs Sales Market Share by Countries (2013-2018)
Figure South America Dermatological Drugs Sales Market Share by Countries in 2017
Table South America Dermatological Drugs Revenue by Countries (2013-2018)
Table South America Dermatological Drugs Revenue Market Share by Countries (2013-2018)
Figure South America Dermatological Drugs Revenue Market Share by Countries in 2017
Figure Brazil Dermatological Drugs Sales and Growth Rate (2013-2018)
Figure Argentina Dermatological Drugs Sales and Growth Rate (2013-2018)
Figure Colombia Dermatological Drugs Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Dermatological Drugs Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Dermatological Drugs Sales by Countries (2013-2018)
Table Middle East and Africa Dermatological Drugs Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Dermatological Drugs Sales Market Share by Countries in 2017
Table Middle East and Africa Dermatological Drugs Revenue by Countries (2013-2018)
Table Middle East and Africa Dermatological Drugs Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Dermatological Drugs Revenue Market Share by Countries in 2013
Figure Middle East and Africa Dermatological Drugs Revenue Market Share by Countries in 2017
Figure Saudi Arabia Dermatological Drugs Sales and Growth Rate (2013-2018)
Figure UAE Dermatological Drugs Sales and Growth Rate (2013-2018)
Figure Egypt Dermatological Drugs Sales and Growth Rate (2013-2018)
Figure Nigeria Dermatological Drugs Sales and Growth Rate (2013-2018)
Figure South Africa Dermatological Drugs Sales and Growth Rate (2013-2018)
Table Global Dermatological Drugs Sales by Type (2013-2018)
Table Global Dermatological Drugs Sales Share by Type (2013-2018)
Table Global Dermatological Drugs Revenue by Type (2013-2018)
Table Global Dermatological Drugs Revenue Share by Type (2013-2018)
Figure Global Prescription-Based Drugs Sales Growth (2013-2018)
Figure Global Prescription-Based Drugs Price (2013-2018)
Figure Global Over-the-Counter Drugs Sales Growth (2013-2018)
Figure Global Over-the-Counter Drugs Price (2013-2018)
Table Global Dermatological Drugs Sales by Application (2013-2018)
Table Global Dermatological Drugs Sales Share by Application (2013-2018)
Figure Global Skin Infections Sales Growth (2013-2018)
Figure Global Psoriasis Sales Growth (2013-2018)
Figure Global Dermatitis Drugs Sales Growth (2013-2018)
Figure Global Other Sales Growth (2013-2018)
Figure Global Dermatological Drugs Sales, Revenue and Growth Rate (2018-2023)
Table Global Dermatological Drugs Sales Forecast by Regions (2018-2023)
Table Global Dermatological Drugs Market Share Forecast by Regions (2018-2023)
Figure North America Sales Dermatological Drugs Market Forecast (2018-2023)
Figure Europe Sales Dermatological Drugs Market Forecast (2018-2023)
Figure Asia-Pacific Sales Dermatological Drugs Market Forecast (2018-2023)
Figure South America Sales Dermatological Drugs Market Forecast (2018-2023)
Figure Middle East and Africa Sales Dermatological Drugs Market Forecast (2018-2023)
Table Global Dermatological Drugs Sales Forecast by Type (2018-2023)
Table Global Dermatological Drugs Market Share Forecast by Type (2018-2023)
Table Global Dermatological Drugs Sales Forecast by Application (2018-2023)
Table Global Dermatological Drugs Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List
  • Global Acne Drugs Market Insights, Forecast to 2025
    Published: 17-Oct-2018        Price: US 3900 Onwards        Pages: 113
    In 2017, the global Acne Drugs market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. The objectives of this study are to define, segment, and project the size of the Acne Drugs market based on company, product type, application and key regions. This report studies the global market size of Acne Drugs in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of A......
  • Chronic Urticaria Or Hives - Pipeline Review, H2 2018
    Published: 16-Oct-2018        Price: US 2000 Onwards        Pages: 77
    Chronic Urticaria Or Hives - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chronic Urticaria Or Hives - Pipeline Review, H2 2018, provides an overview of the Chronic Urticaria Or Hives (Dermatology) pipeline landscape. Chronic urticaria also known as hives, are an outbreak of swollen, pale red bumps, patches, or welts on the skin that appear suddenly either as a result of allergies......
  • Epidermolysis Bullosa - Pipeline Review, H2 2018
    Published: 16-Oct-2018        Price: US 2000 Onwards        Pages: 122
    Epidermolysis Bullosa - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Epidermolysis Bullosa - Pipeline Review, H2 2018, provides an overview of the Epidermolysis Bullosa (Dermatology) pipeline landscape. Epidermolysis bullosa (EB) is a group of inherited bullous disorders characterized by blister formation in response to mechanical trauma. Symptoms include blistering of skin, defor......
  • Vitiligo - Pipeline Review, H2 2018
    Published: 16-Oct-2018        Price: US 2000 Onwards        Pages: 102
    Vitiligo - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Vitiligo - Pipeline Review, H2 2018, provides an overview of the Vitiligo (Dermatology) pipeline landscape. Vitiligo is a condition in which skin loses melanin, the pigment that determines the color of skin, hair and eyes. Symptoms include premature whitening or graying of the hair on scalp, eyelashes, eyebrows or beard, loss......
  • Rosacea - Pipeline Review, H2 2018
    Published: 16-Oct-2018        Price: US 2000 Onwards        Pages: 66
    Rosacea - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Rosacea - Pipeline Review, H2 2018, provides an overview of the Rosacea (Dermatology) pipeline landscape. Rosacea is a chronic and potentially life-disruptive disorder primarily of the facial skin, often characterized by flare-ups and remissions. Symptoms include frequent redness of the face, or flushing, small, red lines unde......
  • Acne Vulgaris - Pipeline Review, H2 2018
    Published: 16-Oct-2018        Price: US 2000 Onwards        Pages: 186
    Acne Vulgaris - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Acne Vulgaris - Pipeline Review, H2 2018, provides an overview of the Acne Vulgaris (Dermatology) pipeline landscape. Acne vulgaris is a chronic skin disease involving blockage and inflammation of pilosebaceous follicles. Symptoms include crusting of skin bumps, cysts, papules (small red bumps), scarring of the skin and ......
  • Global Dermal Filler Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 15-Oct-2018        Price: US 3480 Onwards        Pages: 135
    Dermal filler is an injectable drug used to diminish facial lines and restore volume and fullness in the face. It is used to plump thin lips, soften facial creases and wrinkles, enhance shallow contours, and improve the appearance of recessed scars. One of the aspects of modern life, which is considered as essential by men as well as women is appearance. The urge to look as good as they feel has led to the notable growth in the cosmetology industry. Scope of the Report: ......
  • Global Facial Injectables Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 11-Oct-2018        Price: US 3480 Onwards        Pages: 148
    Injectables are a combination of dermal fillers and Botox used in facial aesthetic treatments, which help reduce wrinkles and play a crucial role in rejuvenating facial skin for smoother and younger look. These are injected under the skin or lips to plump up the tissues and gently lift it to restore collagen lost due to aging. Collagen and HA provide essential support to skin and help it retain its elasticity. The glabellar lines, wrinkles, and lines can be reduced with facial aesthetic treatmen......
  • Frontier Pharma: Orphan and Rare Dermatological Diseases - First-in-Class Therapies Demonstrate Potential Disease-Modifying Effects in Areas of High Unmet Need Such as Epidermolysis Bullosa
    Published: 11-Oct-2018        Price: US 6995 Onwards        Pages: 86
    Orphan and rare dermatological diseases are considerably diverse in terms of pathophysiology, clinical presentation and disease severity. Many of these conditions are extremely debilitating and can even be life-threatening in some cases. Disease visibility can also have a profoundly negative impact on patient confidence. Unmet need within the orphan and rare dermatology market is extremely high with some diseases having no effective treatments. The market is highly genericized and dom......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs